VirtualDrugDevelopment.com
Title
Virtual Drug Development, Inc.
Description
Excerpted from the website:
- Advances in synthetic chemistry and drug screening techniques have flooded the pharmaceutical industry with potential new drugs. At the same time, industry consolidation and financial pressures on R&D budgets have reduced the ability of biotech and pharmaceutical companies to develop early stage drugs. As a result of these market forces, large pharmaceutical companies have restricted their drug development activities to "blockbuster" drugs ($1 billion revenues) with proven efficacy. Promising early-stage drugs developed in emerging biotech and pharmaceutical companies, and university research laboratories are being shelved.
Languages
English
Contact
Additional Information
External Links
Categories:
- Agrobioterrorism
- Altman
- Ann Arbor
- Anthrax
- Anti-fungal
- Anti-infective
- Antimicrobial
- Bacillus Anthracis
- Biopharmaceutical
- Bioterrorism
- Brentwood
- Cancer
- Candida
- Cardiovascular
- Crop Protection
- David W
- Hanna
- Huntsville
- Infectious Disease
- Larry DeLucas
- NAD Synthetase
- Pharmaceutical
- Philip C
- R
- Research
- Stephen Porter
- UAB
- UABCBSE
- UMICH
- VDDI
- Virtual
- Virtual Drug Development